Virtual Dialogue: Addressing AMR in paediatric cancer care

Children living with cancer are among the most vulnerable to infections, as both the disease and its treatment can severely weaken their immune systems. Infections remain a leading cause of morbidity and mortality in paediatric oncology, and the growing threat of antimicrobial resistance (AMR) is making these infections increasingly difficult to prevent and treat. Rising resistance to commonly used antibiotics and antifungals can delay or compromise cancer treatment, reduce quality of life, and negatively affect survival outcomes.

Addressing AMR in paediatric cancer care requires coordinated action across sectors and disciplines. Challenges such as limited access to child-appropriate antimicrobials, gaps in clinical evidence, inadequate diagnostics, and the misuse or overuse of antimicrobial medicines underscore the need for stronger collaboration between healthcare professionals, researchers, policymakers, civil society, and affected communities.

This UICC Virtual Dialogue will explore how collaborative, people-centred approaches can help strengthen infection prevention and control, antimicrobial stewardship, and access to appropriate treatment for children with cancer. 

 Speakers

• Dr Najy AlSayed, Menarini Group
• Dr Lillian Sung, The Hospital for Sick Children
• Prof. Bob Phillips, University of York
• Dr Alicia Demirjian, UK Health Security Agency